APOL1长期肾移植结局网络(APOLLO):设计与理由
APOLLO是由NIH资助的前瞻性观察研究,评估基于供受体APOL1基因型的近期非洲裔供肾移植结局。研究将纳入2614例 deceased 供受体对及活体供肾等,结果旨在指导利用APOL1基因型数据评估供肾质量、增加移植肾数量并提高活体捐献安全性。
要点
- APOLLO前瞻性评估基于供受体APOL1基因型的肾移植结局。
- 计划评估2614例 deceased 供受体对及其他活体供肾和未配对供肾。
- 结果将指导利用APOL1基因型数据改善供肾质量评估。
核心结论
- APOLLO将评估基于供受体APOL1基因型的肾移植结局,以指导供肾质量评估和活体捐献安全。
研究设计与样本
- NIH赞助的前瞻性观察研究,计划评估2614例 deceased 供受体对,以及额外活体供受体对和未配对 deceased 供肾。
关键数值与推荐
- 计划评估2614例 deceased 供受体对。
临床怎么用
- 结果可能用于指导利用APOL1基因型数据评估 deceased 供肾质量,并可能增加移植肾数量、降低弃用率、提高活体捐献安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Much of the higher risk for end-stage kidney disease (ESKD) in African American individuals relates to ancestry-specific variation in the apolipoprotein L1 gene (APOL1). Relative to kidneys from European American deceased-donors, kidneys from African American deceased-donors have shorter allograft survival and African American living-kidney donors more often develop ESKD. The National Institutes of Health (NIH)-sponsored APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) is prospectively assessing kidney allograft survival from donors with recent African ancestry based on donor and recipient APOL1 genotypes. METHODS: APOLLO will evaluate outcomes from 2614 deceased kidney donor-recipient pairs, as well as additional living-kidney donor-recipient pairs and unpaired deceased-donor kidneys. RESULTS: The United Network for Organ Sharing (UNOS), Association of Organ Procurement Organizations, American Society of Transplantation, American Society for Histocompatibility and Immunogenetics, and nearly all U.S. kidney transplant programs, organ procurement organizations (OPOs), and histocompatibility laboratories are participating in this observational study. APOLLO employs a central institutional review board (cIRB) and maintains voluntary partnerships with OPOs and histocompatibility laboratories. A Community Advisory Council composed of African American individuals with a personal or family history of kidney disease has advised the NIH Project Office and Steering Committee since inception. UNOS is providing data for outcome analyses. CONCLUSION: This article describes unique aspects of the protocol, design, and performance of APOLLO. Results will guide use of APOL1 genotypic data to improve the assessment of quality in deceased-donor kidneys and could increase numbers of transplanted kidneys, reduce rates of discard, and improve the safety of living-kidney donation.
引用
- Freedman BI, Moxey-Mims MM, Alexander AA, et al. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale. Kidney Int Rep. 2019. PMID: 32154449. doi:10.1016/j.ekir.2019.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。